Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “breast cancer”

Adapting a Mammography Decision Aid to Support Women Living in a Community Contaminated by PFASCompleted
NCT06098118NAUpdated Aug 18, 2026
Sponsor: Trustees of Dartmouth College
Breast Cancer Screening
United States
Impact Of Intermittent And Water-Only Fasting On Gene Expression And Tumor Markers In Breast CancerCompleted
NCT07440784NAUpdated Aug 18, 2026
Sponsor: Khyber Medical University Peshawar
Breast Cancer
Pakistan
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian CancerRecruiting
NCT06799065Phase 1Updated Aug 18, 2026
Sponsor: Accent Therapeutics
Advanced Solid Tumors · Breast Cancer Recurrent · Ovarian Cancer · High-grade Serous Ovarian Carcinoma
United States
AI-Based Symptom Management for Post-Treatment Breast Cancer SurvivorsNot Yet Recruiting
NCT07770243NAUpdated Aug 18, 2026
Sponsor: Hong Kong Metropolitan University
Breast Cancer · Cancer Survivorship
A Study of BEBT-209 Plus Chemotherapy in Patients With Locally Advanced or Metastatic Triple-Negative Breast CancerRecruiting
NCT07544056Phase 2, Phase 3Updated Aug 18, 2026
Sponsor: BeBetter Med Inc
Locally Advanced Triple-negative Breast Cancer · Metastatic Triple-negative Breast Cancer
China
Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast CancerActive Not Recruiting
NCT03939897Phase 1Updated Aug 18, 2026
Sponsor: National Cancer Institute (NCI)
Anatomic Stage IV Breast Cancer AJCC v8 · Metastatic Breast Carcinoma · Metastatic HER2-Negative Breast Carcinoma · Metastatic Hormone Receptor-Positive Breast Carcinoma
United States
Metarrestin (ML-246) in Subjects With Metastatic Solid TumorsRecruiting
NCT04222413Phase 1Updated Aug 18, 2026
Sponsor: National Cancer Institute (NCI)
Advanced Solid Tumors · Metastatic Pancreatic Cancer · Pediatric Solid Tumor · Advanced Breast Cancer
United States
A Phase 1a/1b, First-Time-in-Human Study of CT-202, a Nectin-4 Directed Bispecific Antibody, in Participants With Recurring Triple Negative Breast, Colorectal, Urothelial CancersRecruiting
NCT07545122Phase 1Updated Aug 18, 2026
Sponsor: Context Therapeutics Inc.
Triple Negative Breast Cancer (TNBC) · Colorectal Cancer · Urothelial Cancer
Australia
Romiplostim N01 for Injection for Secondary Prophylaxis of CIT in Breast CancerNot Yet Recruiting
NCT07771881Phase 2Updated Aug 18, 2026
Sponsor: Fudan University
Thrombocytopenia Chemotherapy Induced
China
Neoadjuvant Pyrotinib in HR-positive and HER2-low High-risk Early Breast CancerActive Not Recruiting
NCT06144944Phase 3Updated Aug 18, 2026
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Breast Cancer Invasive · Hormone-receptor-positive Breast Cancer · HER2 Low Breast Carcinoma · Early-stage Breast Cancer
China
A Phase I Trial of LY3143921 Hydrate in Solid TumoursCompleted
NCT03096054Phase 1Updated Aug 18, 2026
Sponsor: Cancer Research UK
Colorectal Cancer · High Grade Serous Ovarian Cancer · Non Small-cell Lung Cancer (Squamous Cell Variant) · Urothelial Cancer
United Kingdom
Paclitaxel Polymeric Micelles and Carboplatin in Combination With Iparomilimab and Tuvonralimab Neoadjuvant Therapy for Triple-negative Breast Cancer（UPGRADE-TNBC）Enrolling By Invitation
NCT06910072Phase 2, Phase 3Updated Aug 18, 2026
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Triple-Negative Breast Cancer (TNBC) · Neoadjuvant Therapy
China
Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing ChemotherapyActive Not Recruiting
NCT04724499NAUpdated Aug 18, 2026
Sponsor: Dana-Farber Cancer Institute
Breast Cancer · Chemotherapy Effect · Exercise Therapy · Cognitive Change
United States
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic CancerRecruiting
NCT03412877Phase 2Updated Aug 18, 2026
Sponsor: National Cancer Institute (NCI)
Endocrine Tumors · Non-Small Cell Lung Cancer · Ovarian Cancer · Breast Cancer
United States
Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast CancerRecruiting
NCT06888388N/AUpdated Aug 18, 2026
Sponsor: Sir Mortimer B. Davis - Jewish General Hospital
Breast Cancer Surgery
United States, Australia, Belgium, Canada, Japan +3 more
Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer.Active Not Recruiting
NCT03616587Phase 1Updated Aug 18, 2026
Sponsor: AstraZeneca
ER+ HER2- Advanced Breast Cancer
United States, Spain, United Kingdom
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic AnalysisRecruiting
NCT01441089N/AUpdated Aug 18, 2026
Sponsor: National Cancer Institute (NCI)
Prostate Cancer · Breast Cancer · Lung Cancer · Ovarian Cancer
United States
Breast Mammogram and Tissue StudyCompleted
NCT00475761N/AUpdated Aug 18, 2026
Sponsor: National Cancer Institute (NCI)
Breast Neoplasms
United States
Phase I Study of BEBT-209 in Women With Advanced Breast CancerCompleted
NCT06047184Phase 1Updated Aug 18, 2026
Sponsor: BeBetter Med Inc
Advanced Breast Cancer
China
A Novel Approach Utilizing Organ Specific Age ProteomicsRecruiting
NCT06789653N/AUpdated Aug 18, 2026
Sponsor: UNC Lineberger Comprehensive Cancer Center
Breast Cancer
United States
Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric CancerCompleted
NCT03030404N/AUpdated Aug 18, 2026
Sponsor: National Cancer Institute (NCI)
Stomach Neoplasms · Stomach Cancer · Gastric Adenocarcinoma and Proximal Polyposis of the Stomach (GAPPS) · Hereditary Diffuse Gastric Cancer (HDGC)
United States
Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In SituRecruiting
NCT06218303Phase 1Updated Aug 18, 2026
Sponsor: Finn, Olivera, PhD
Ductal Carcinoma in Situ
United States
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid TumorsRecruiting
NCT06618287Phase 1, Phase 2Updated Aug 18, 2026
Sponsor: Bristol-Myers Squibb
Lung Cancer · Breast Cancer
United States, Australia, Canada, Chile, France +5 more
A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast CancerActive Not Recruiting
NCT03701334Phase 3Updated Aug 18, 2026
Sponsor: Novartis Pharmaceuticals
Early Breast Cancer
United States, Argentina, Australia, Austria, Belgium +15 more
Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast CancerRecruiting
NCT06993506N/AUpdated Aug 18, 2026
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
HER2-negative Breast Cancer · Recurrence · Metastasis
China

Previous page Next page